The life threatening adverse effects of psychotropic drugs: A case report

Turk Psikiyatri Dergisi

Volumn 17, Issue 2, 2006, Pages

  Tiryaki, Ahmet ^a   Kandemir, Gökhan ^a   Ak, Ismail ^a  

^a NONE

Author keywords

Differential diagnosis; Neuroleptic malignant syndrome; Serotonin syndrome; Symptoms

Indexed keywords

EID: 33745191424     PISSN: 13002163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Atbasşoǧlu EC, Devrimci Özgüven H, Saka MC et al. (2004) Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome. J Clin Psychiatry 65: 12, 1724-1725.
2. Avarello TP, Cottone S (2002) Serotonin syndrome: a reported case. Neurol Sci, 23: S55-S56.
3. Bertolín-Guillèn J-M, Climent-Díaz B, Navarré-Gimeno A (2004) Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine. Eur Psychiatry,(19): 456-458.
4. Birmes P, Coppin D, Schmitt L et al. (2003) Serotonin syndrome: a brief review. CMAJ, 168 (11):1439-1442.
5. Brown TM (2004) Nitroglycerine in the treatment of the serotonin syndrome. Am J Emerg Med, 22 (6): 510.
6. Bryant SM (2004) Serotonin syndrome resulting from an herbal detox coctail. Am J Emerg Med, 22 (7): 625-626.
7. Chandran GJ, Mikler JR, Keegan DL (2003) Neuroleptic malignant syndrome: a case report and discussion. CMAJ, 169 (5):439-442.
8. Duggal HS, Fetchko J (2002) Serotonin syndrome and atypical antipsychotics. Am J Psychiatry, 159, 4; 672-673.
9. Garside S, Rosebush PI (2003) Serotonin syndrome not a benign toxidrome. CMAJ, 169 (6): 543.
10. Hyashi H, Kawakatsu S, Watanabe K et al. (2002) Neuroleptic malignant syndrome complicated by massive intestinal bleeding in a patient with chronic renal failure. Prog Neuoropsychopharmacol Biol Psychiatry, (26):1225-1227.
11. Keck PE, Arnold LM (2000) The serotonin syndrome. Psychiatr Ann, 30, 5; 333-343.
12. Kontaxakis VP, Havaki-Kontaxaki BJ, Christodoulou NG et al. (2000) Olanzapine-associated neuroleptic malignant syndrome: is there any overlap with the serotonin syndrome? Eur Neuropsychopharmacol, 10 (Suppl. 3) S313.
13. Kontaxakis VP, Havaki-Kontaxaki BJ, Christodoulou NG et al. (2002) Olanzapine-associated neuroleptic malignant syndrome. Prog Neuoropsychopharmacol Biol Psychiatry, (26):897-902.
14. Liebold J, Patel V, Hasan RA (2004) Neuroleptic malignant syndrome associated with ziprasdidone in an adolescent. Clin Ther, 26 (7):1105-1108.
15. Reeves RR, Torres RA, Liberto V et al. (2002) Atypical neuroleptic malignant syndrome associated with olanzapine. Pharmacotherapy, 22(5) 641-644.
16. Rivera A, Gaudino W, Weiss L (2003) Serotonin syndrome in a patient taking tramadol and nefazadone concomitantly: a case report. Arch Phys Med Rehabil, 84: A-23.
17. Stanfield SC, Privette T (2000) Neuroleptic malignant syndrome associated with olanzapine therapy: a case report. J Emerg Med, 19 (4):355-357.
18. Wren P, Frizzell LA, Keltner NL et al. (2003) Three potentially fatal adverse effects of psychotropic medications. Perspect Psychiatr Care, 39 (2): 75-81.